Normal luminal bacteria, especially bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2 microglobulin transgenic rats

Journal of Clinical Investigation

Volumn 98, Issue 4, 1996, Pages 945-953

  Rath, Heiko C ^e   Herfarth, Hans H ^e   Ikeda, Jack S ^a   Grenther, Wetonia B ^e   Hamm Jr , Thomas E ^e   Balish, Edward ^b   Taurog, Joel D ^c   Hammer, Robert E ^d   Wilson, Ken H ^a   Sartor, R Balfour ^e  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Bacteroides; experimental colitis; germfree; specific pathogen free

Indexed keywords

BETA 2 MICROGLOBULIN; HLA B27 ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDES; COLITIS; CONTROLLED STUDY; DISEASE COURSE; GASTRITIS; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INTESTINE FLORA; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

EID: 9544226450     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118878     Document Type: Article

References (57)

1. Sartor, R.B. 1995. Current concepts of etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol. Clin. North Am. 24:475-506.
2. Sartor, R.B. 1995. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation. In Inflammatory Bowel Disease. J.B. Kirsncr and R.G. Shorter, editors. Williams & Wilkins, Baltimore, MD. 96-124.
3. Sutherland, L., J. Singleton, J. Sessions, S. Hanauer, E. Krawitt, G. Rankin, R. Summers, H. Mekhjian, N. Greenberger, M. Kelly, et al. 1991. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut. 32: 1071-1075.
4. Peppercorn, M.A. 1993. Is there a role for antibiotics as primary therapy in Crohn's ileitis? J. Clin. Gastroenterol. 17:235-237.
5. Graham, D.Y., M.T. Al-Assi, and M. Robinson. 1995. Prolonged remission in Crohn's disease following therapy for Mycobacterium paratuberculosis infection. Gastroenterology. 108:826a. (Abstr.)
6. Turunen, U. 1994. A double-blind, placebo-controlled, six-month ciprofloxacin treatment improves prognosis in ulcerative colitis. Gastroenterology. 106:786a. (Abstr.)
7. McCall, R.D., S. Haskill, E.M. Zimmermann, P.K. Lund, R.C. Thompson, and R.B. Sartor. 1994. Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology. 106:960-972.
8. Sartor, R.B., W.J. Cromartie, D.W. Powell, and J.H. Schwab. 1985. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology. 89:587-595.
9. Lichtman, S.N., J. Keku, J.H. Schwab, and R.B. Sartor. 1991. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology. 100:513-519.
10. Lichtman, S.N., J. Wang, R.B. Sartor, C. Zhang, D.E. Bender, F.G. Dalldorfer, and J.H. Schwab. 1995. Reactivation of arthritis induced by small bowel bacterial overgrowth in rats: role of cytokines, luminal bacteria and bacterial polymers. Infect. Immun. 63:2295-2301.
11. Yamada, T., E. Deitch, R.D. Specian, M.A. Perry, R.B. Sartor, and M.B. Grisham. 1993. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation. 17:641-662.
12. Sartor, R.B., D.E. Bender, T. Grenther, and L.C. Holt. 1994. Absolute requirement for ubiquitous luminal bacteria in the pathogenesis of chronic intestinal inflammation. Gastroenterology. 104:767a. (Abstr.)
13. Donaldson, R.M., Jr. 1981. Normal bacterial population of the intestine and their relation to intestinal function. N. Engl. J. Med. 270:938-943.
14. Krook, A., B. Lindstrom, J. Kjellander, G. Jarnerot, and L. Bodin. 1981. Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals. J. Clin. Pathol. 34:645-650.
15. van de Merwe, J.P., A.M. Schröder, F. Wensinck, and M.P. Hazenberg. 1988. The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives. Scand. J. Gastroenterol. 23:1125-1131.
16. Auer, I.O., A. Roder, F. Wensinck, J.P. van de Merwe, and H. Schmidt. 1983. Selected bacterial antibodies in Crohn's disease and ulcerative colitis. Scand. J. Gastroenterol. 18:217-223.
17. Onderdonk, A.B., M.L. Franklin, and R.L. Cisneros. 1981. Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infect. Immun. 32:225-231.
18. Severijnen, A.J., R. van Kleef, M.P. Hazenberg, and J.P. van de Merwe. 1989. Cell wall fragments from major residents of the human intestinal flora induce chronic arthritis in rats. J. Rheumatol. 16:1061-1068.
19. Stimpson, S.A., R.R. Brown, S.K. Anderle, D.G. Klapper, R.L. Clark, W.J. Cromartie, and J.H. Schwab. 1986. Arthropathic properties of cell wall polymers from normal flora bacteria. Infect. Immun. 51:240-249.
20. Abbas, A.K., A.H. Lichtman, and J.S. Pober. 1994. The major histocompatibility complex. In Cellular and Molecular Immunology. A.K. Abbas, A.H. Lichtman, and J.S. Pober, editors. W.B. Saunders Co., Philadelphia. 96-114.
21. Inman, R.D., and R.H. Scofield. 1994. Etiopathogencsis of ankylosing spondylitis and reactive arthritis. Curr. Opin. Rheumatol. 6:360-370.
22. Sartor, R.B., and S.N. Lichtman. 1993. Mechanisms of systemic inflammation associated with intestinal injury. In Inflammatory Bowel Disease: From Bench to Bedside. S.R. Targan and F. Shanahan, editors. Williams & Wilkins, Baltimore, MD. 210-229.
23. Hammer, R.E., S.D. Maika, J.A. Richardson, J.P. Tang, and J.D. Taurog. 1990. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell. 63:1099-1112.
24. Taurog, J.D., S.D. Maika, WA. Simmons, M. Breban, and R.E. Hammer. 1993. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J. Immunol. 150:4168-4178.
25. Taurog, J.D., J.A. Richardson, J.T. Croft, WA. Simmons, M. Zhou, J.L. Fernandez Sueiro, E. Balish, and R.E. Hammer. 1994. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp Med. 180:2359-2364.
26. Brinster, R.L., H.Y. Chen, M.E. Trumbauer, M.K. Yagle, and R.D. Palmiter. 1985. Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc. Natl. Acad. Sci. USA. 82:4438-4442.
27. MacDonald, T.T., and P.B. Carter. 1978. Contact sensitivity in germfree mice. J. Reticuloendothel. Soc. 24:287-293.
28. Orcutt, R.P., F.J. Gianni, and R.J. Judge. 1987. Development of an "altered Schaedler flora" for NCl gnotobiotic rodents. Microecol. Ther. 17:59a. (Abstr.)
29. Grisham, M.B., J.N. Benoit, and D.N. Granger. 1990. Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol. 186:729-742.
30. Siegling, A., M. Lehmann, C. Platzer, F. Emmrich, and H.D. Volk. 1994. A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J. Immunol. Methods. 177:23-28.
31. Crofford, L.J., H. Sano, K. Karalis, E.L. Webster, E.A. Goldmuntz, G.P. Chrousos, and R.L. Wilder. 1992. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J. Clin. Invest. 90:2555-2564.
32. Dijkema, R., H. van der Meide, M. Dubbeld, M.W. Caspers, Jr., and H. Schellekens. 1986. Cloning, expression and purification of rat IFN gamma. Methods Enzymol. 119:453-463.
33. Eisenberg, S.P., M.T Brewer, E. Verderber, P. Heimdal, B.J. Brandhuber, and R.C. Thompson. 1991. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc. Nail. Acad. Sci. USA. 88:5232-5236.
34. Kwon, J., I. Chung, and E. Benveniste. 1993. Cloning and sequence analysis of the rat tumor necrosis factor-encoding gene. Gene. 132:227-236.
35. Herfarth, H.H., S.P. Mohanty, H.C. Rath, S. Tonkmogy, and R.B. Sartor. 1996. Interleukin-10 suppresses chronic, experimental granulomatous inflammation induced by bacterial cell wall polymers. Gut. In press.
36. Nishida, T., N. Nishino, M. Takano, Y. Sekiguchi, K. Kawai, K.O. Mizuno, S. Nakai, Y. Masui, and Y. Hirai. 1989. Molecular cloning and expression of rat interleukin 1 alpha cDNA. J. Biochem. 105:351-357.
37. Nudel, U., R. Zakut, M. Shani, S. Neuman, Z. Levy, and D. Vaffe. 1983. The nucleotide sequence of the rat cytoplasmatic beta-actin gene. Nucleic Acids Res. 11:1759-1771.
38. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A.C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:253-261.
39. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:263-274.
40. Rath, H.C., D.E. Bender, L.C. Holt, T. Grenther, J.D. Taurog, R.E. Hammer, and R.B. Sartor. 1995. Metronidazole attenuates colitis in HLA-B27/hβ2 microglobulin transgenic rats: a pathogenic role for anacrohic bacteria. Clin. Immunol. Immunopathol. 76:S45. (Abstr.)
41. Bjarnason, I., J. Hayllar, P. Smethurst, A. Price, and M. J. Gumpel. 1992. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut. 33:1204-1208.
42. Videla, S., J. Vilaseca, F. Guarner, A. Salas, F. Treserra, E. Crespo, M. Antolin, and J.R. Malagelada. 1994. Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut. 35:1090-1097.
43. Wells, C.L., M.A. van de Westerlo, R.P. Jechorek, B.A. Feltis, T.D. Wilkins, and S.L. Erlandsen. 1996. Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes. Gastroenterology. 110:1429-1437.
44. Davis, S.W., L.C. Holt, and R.B. Sartor. 1990. Luminal bacteria and bacterial polymers potentiate indomethacin-induced intestinal injury in the rat. Gastroenterology. 98:444a. (Abstr.)
45. Lichtman, S.N., E.E. Okoruwa, J. Keku, J.H. Schwab, and R.B. Sartor. 1992. Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth. J. Clin. Invest. 90:1313-1322.
46. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature (Lond.). 359:693-699.
47. Oberhuber, G., C, Pïspök, C. Oesterreicher, R. Maier-Dobersberger, F. Pfeffel, G. Novacek, J. Hammer, C. Zauner, A. Kummer, H. Vogelsang, R. Pötzi, F. Wrba, and T. Radasziewics. 1996. Crohn's disease of the stomach is histologically characterized by focal active gastritis. Gastroenterology. 110:982a. (Abstr.)
48. Aiko, S., and M.B. Grisham. 1995. Spontaneous intestinal inflammation and nitric oxide metabolism in HLA B27 transgenic rats. Gastroenterology. 109: 142-150.
49. Sartor, R.B. 1994. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology. 106:533-539.
50. Herfarth, H.H., and R.B. Sartor. 1994. Cytokine regulation of experimental intestinal inflammation. Curr. Opin. Gastroenterol. 10:625-632.
51. Esser, R.E., S.A. Stimpson, W.J. Cromartie, and J.H. Schwab. 1985. Reactivation of streptococcal cell wall-induced arthritis by homologous and heterologous cell wall polymers. Arthritis Rheum. 28:1402-1411.
52. Stimpson, S.A., R.E. Esser, P.B. Carter, R.B. Sartor, W.J. Cromartie, and J.H. Schwab. 1987. Lipopolysaccharide induces recurrence of arthritis in rat joints previously injured by peptidoglycan-polysaccharide. J. Exp. Med. 165: 1688-1702.
53. Sartor, R.B., H.C. Rath, S.N. Lichtman, and E.A.F van Tol. 1996. Animal models of intestinal and joint inflammation. Bailliere's Clin. Rheumatol. 10: 55-76.
54. Sartor, R.B., T.M. Bond, and J.H. Schwab. 1988. Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury. Infect. Immun. 56:2101-2108.
55. Lichtman, S.N., J. Keku, J.H. Schwab, and R.B. Sartor. 1991. Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth. Infect. Immun. 59:555-562.
56. Granfors, K., S. Jalkanen, R. Von Essen, R. Lahesmaa-Rantala, O. Isomaki, K. Pekkola-Heino, R. Merilahti-Palo, R. Saario, H. Isomaki, and A. Toivanen. 1989. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N. Engl. J. Med. 320:216-221.
57. Granfors, K., S. Jalkanen, A.A. Lindberg, O. Mäki-Ikola, R. Von Essen, R. Lahesmaa-Rantala, H. Isomaki, R. Saario, W.J. Arnold, and A. Toivanen. 1990. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet. 335:685-688.